Приказ основних података о документу
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
dc.creator | Riad, Abanoub | |
dc.creator | Schünemann, Holger | |
dc.creator | Sameh, Attia | |
dc.creator | Poklepović Peričić, Tina | |
dc.creator | Franka Žuljević, Marija | |
dc.creator | Jürisson, Mikk | |
dc.creator | Kalda, Ruth | |
dc.creator | Lang, Katrin | |
dc.creator | Morankar, Sudhakar | |
dc.creator | Ali Yesuf, Elias | |
dc.creator | Mekhemar, Mohamed | |
dc.creator | Danso-Appiah, Anthony | |
dc.creator | Sofi-Mahmudi, Ahmad | |
dc.creator | Pérez-Gaxiola, Giordano | |
dc.creator | Dziedzic, Arkadiusz | |
dc.creator | Apóstolo, João | |
dc.creator | Cardoso, Daniela | |
dc.creator | Marc, Janja | |
dc.creator | Moreno-Casbas, Mayte | |
dc.creator | Shey Wiysonge, Charles | |
dc.creator | Qaseem, Amir | |
dc.creator | Gryschek, Anna | |
dc.creator | Tadić, Ivana | |
dc.creator | Hussain, Salman | |
dc.creator | Ahmed Khan, Mohammed | |
dc.creator | Klugarova, Jitka | |
dc.creator | Pokorna, Andrea | |
dc.creator | Koščík, Michal | |
dc.creator | Klugar, Miloslav | |
dc.date.accessioned | 2022-07-29T11:26:56Z | |
dc.date.available | 2022-07-29T11:26:56Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1660-4601 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/4212 | |
dc.description.abstract | Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses' side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines. | sr |
dc.language.iso | en | sr |
dc.publisher | MDPI | |
dc.relation | This study protocol preparation was funded by Masaryk University, grant numbers MUNI/IGA/1543/2020 and MUNI/A/1608/20 | sr |
dc.rights | openAccess | sr |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | International Journal of Environmental Research and Public Health | sr |
dc.subject | COVID-19 | sr |
dc.subject | cohort studies | |
dc.subject | cross-sectional studies | |
dc.subject | drug-related side effects and adverse reactions | |
dc.subject | health personnel | |
dc.subject | mass vaccination | |
dc.subject | prevalence. | |
dc.title | COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects | sr |
dc.type | article | sr |
dc.rights.license | BY | sr |
dc.citation.volume | 18 | |
dc.citation.issue | 15 | |
dc.citation.spage | 7859 | |
dc.citation.rank | M21 | |
dc.identifier.wos | 000681945000001 | |
dc.identifier.doi | 10.3390/ijerph18157859 | |
dc.identifier.scopus | 2-s2.0-85111058565 | |
dc.identifier.fulltext | http://farfar.pharmacy.bg.ac.rs/bitstream/id/11502/COVID-19_Vaccines_Safety_pub_2021.pdf | |
dc.type.version | publishedVersion | sr |